🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Advanced Endometrial Carcinoma

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites📍 Phoenix📍 Los Angeles📍 Orlando Iovance Biotherapeutics, Inc. · Tests: Lifileucel A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites📍 Birmingham📍 Birmingham📍 Birmingham Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046054, pembrolizumab A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site📍 Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: SSGJ-707, carboplatin, paclitaxel Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer NCT06584032Phase 317 sites📍 Beijing📍 Chongqing📍 Fuzhou Hutchmed · Tests: fruquintinib, sintilimab, paclitaxel, doxorubicin NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife) NCT06890273n/a49 sites📍 Amberg📍 Bad Nauheim📍 Bautzen AstraZeneca Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251Phase 1, Phase 213 sites📍 New Haven📍 Sarasota📍 Tampa Avenzo Therapeutics, Inc. · Tests: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer NCT05112991Phase 219 sites📍 Beijing📍 Chongqing📍 Fuzhou 3D Medicines (Sichuan) Co., Ltd. · Tests: Envafolimab+Lenvatinib, Envafolimab Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341Phase 249 sites📍 Birmingham📍 Palo Alto📍 San Francisco Corcept Therapeutics · Tests: Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites📍 Beverly Hills📍 Los Angeles📍 Palo Alto Pheast Therapeutics · Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery NCT04774419Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intensity modulated radiation therapy (IMRT), Dostarlimab, Hypofractionated IMRT CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981Phase 17 sites📍 Detroit📍 St Louis📍 Canton Sairopa B.V. · Tests: ADU-1805, Pembrolizumab A Phase 1 Study of LNCB74 in Advanced Solid Tumors NCT06774963Phase 114 sites📍 Newport Beach📍 Edgewood📍 Boston NextCure, Inc. · Tests: LNCB74 An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) NCT07044336Phase 3320 sites📍 Tucson📍 La Jolla📍 Los Angeles AstraZeneca · Tests: Puxitatug Samrotecan, Doxorubicin, Paclitaxel QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer NCT06917092Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: QL1706 combined with chemotherapy ± Bevacizumab A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors NCT07383506Phase 112 sites📍 Scottsdale📍 Los Angeles📍 Palo Alto Cogent Biosciences, Inc. · Tests: CGT6297 A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site📍 Shanghai TJ Biopharma Co., Ltd. · Tests: TJ037130 DBC-664 in Adult Patients With Solid Tumors NCT07705035Phase 16 sites📍 Denver📍 Grand Rapids📍 East Brunswick Duboce Biopharmaceuticals, Inc. · Tests: DBC-664 Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors NCT07334119Phase 17 sites📍 Darlinghurst📍 Randwick📍 Waratah Myeloid Therapeutics · Tests: MT-304, MT-304 + Nivolumab A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites📍 Denver📍 Sarasota📍 Detroit IDEAYA Biosciences · Tests: IDE034 A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites📍 Santa Monica📍 New Have📍 Camperdown Kivu Bioscience Inc. · Tests: KIVU-107 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer NCT07270666NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: ctDNA Testing, Blood draw, Surveys, Semi-structured interviews A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors NCT06515613Phase 115 sites📍 Little Rock📍 Beverly Hills📍 Denver Context Therapeutics Inc. · Tests: CTIM-76 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations NCT07109726Phase 1, Phase 220 sites📍 Duarte📍 Irvine📍 Orlando Terremoto Biosciences Inc. · Tests: TER-2013, Fulvestrant injection A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites📍 Los Angeles📍 Denver📍 New Haven GV20 Therapeutics · Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®]
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy